Vineet Laboratories Limited (NSE:VINEETLAB)

Market Cap	768.06M +164.7%
Revenue (ttm)	560.13M -43.4%
Net Income	-101.39M
EPS	-11.04
Shares Out	19.21M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	139,759
Average Volume	103,355
Open	39.21
Previous Close	39.21
Day's Range	38.51 - 40.69
52-Week Range	26.51 - 49.99
Beta	-0.16
RSI	80.92
Earnings Date	May 12, 2026

About Vineet Laboratories

Vineet Laboratories Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API), intermediates, and fine chemicals primarily in India. The company offers intermediates of Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, Piroctone Olanine, and other API intermediates. It also provides fine chemicals and reagents, such as isopropyl-beta-d-thiogalactopyranoside, n-butyl lithium, 4-nitrophenyl phosphate disodium salt, 5-bromo-4-chloro-3-indolyl-beta-d-galactopyranoside, 5-acetyl th...

• Industry: Chemicals
• Sector: Materials
• Founded: 2016
• Employees: 57
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: VINEETLAB